个人简介

    吴丽娟，女，医学博士研究生，硕士生导师，副教授

研究方向

    主要研究方向为中医药对职业病、慢性疾病的机制研究，主持国家自然科学基金1项，主持及参研省部级、厅局级、校级等各级各类课题10余项，公开SCI、北大核心等期刊论文近30余篇，第一作者/通讯作者发表文章12篇。

代表性成果

[1] Wu LJ, He XY, Wang WX, et al. Dahuang Zhechong Pills Suppress Silicosis Fibrosis Progression via p38 MAPK/TGF-β1/Smad Pathway In Vitro. Evid Based Complement Alternat Med. 2021; 2021:6662261. Published 2021 Apr 1. doi:10.1155/2021/6662261

[2] Wu LJ, Long L, Sun JY, et al. Exploring the antioxidant effect of Lactobacillus plantarum SCS2 on mice with type 2 diabetes [published online ahead of print, 2021 Jul 18]. J Food Biochem. 2021; e13781. doi:10.1111/jfbc.13781

[3] Wu LJ, Liu MJ, Liang JT, et al. Ferroptosis as a New Mechanism in Parkinson's Disease Therapy Using Traditional Chinese Medicine. Front Pharmacol. 2021; 12:659584. Published 2021 Jun 7. doi:10.3389/fphar.2021.659584

[4] Wu LJ , He XY ,Liang JT , Liang J , Wang F , Chen DY，Intragastric administration of dahuang zhechong pill modulates TGF-b1/ smad signaling pathway in murine model of experimental silicosis.Journal of King Saud University-Science.32 (2020) 3223, 3229.https://doi.org/10.1016/j.jksus.

[5] He XY, Wu LJ, Wang WX, Xie PJ, Chen YH, Wang F. Amygdalin - A pharmacological and toxicological review. J Ethnopharmacol. 2020; 254:112717. doi:10.1016/j.jep.2020.112717

[6] 吴丽娟,梁静涛,王飞.运用辛甘化阳法治疗抑郁症的理论探讨[J].四川中医,2021,39(11):37-39.

[7]梁静涛,霍之瀛,王敏,何晓艳,吴丽娟^＊.大黄䗪虫丸抗多器官纤维化作用机制的研究进展[J].中国实验方剂学杂志,2021,27(16):237-244.DOI:10.13422/j.cnki.syfjx.20211693.

[8] 吴丽娟,何晓艳,梁静涛,梁洁,张玉蝶.大黄䗪虫丸经p38 MAPK/NF-κB/TGF-β_1通路抑制小鼠硅肺纤维化的机制探讨[J].中国实验方剂学杂志,2021,27(11):27-34.DOI:10.13422/j.cnki.syfjx.20211190.

[9] 梁静涛,何晓艳,吴丽娟^＊. 基于“异病同治”理论探讨当归芍药散经COX-2/PGF(2α)轴治疗原发性痛经和阿尔茨海默病的作用机制[J]. 四川中医,2022,06:36-40.